Search

You searched for "outpatient"

1490 results found

FDA Approved Lenire Expands Number of US Clinics

1 March 2024 | Company Profiles, Contracts & Distributors, Research & Development
Neuromod Devices, the medical technology company that developed tinnitus treatment device, Lenire, has partnered with an additional 24 new US clinics to address the significant demand for the FDA Approved tinnitus treatment device.

From the editor May/Jun 2024

3 May 2024 |
Declan Costello, MA, MBBS, FRCS(ORL-HNS),Consultant Ear, Nose and Throat Surgeon, Wexham Park Hospital, Slough, Berkshire, UK. E: d.costello@nhs.netTW / X: @Voicedoctor_uk One of the privileges of editing this magazine is interviewing senior figures within our specialty; so, it was wonderful...

BCIG Annual Meeting 2024

30 April 2024 -1 May 2024 | ENTA-Audiology - Adult, ENTA-Audiology - Paediatric, ENTA-Auditory Implants
Jameel Muzaffar, Consultant ENT Surgeon, University Hospitals Birmingham, Birmingham, UK. The British Cochlear Implant Group (BCIG) Meeting 2024, hosted by the North East Cochlear Implant Programme (NECIP), was entitled ‘Learning journeys – bringing people together’. The gathering was a showcase...

Body self-image – the ENT perspective

1 January 2017 | | ENTA-ENT, ENTA-Paediatrics, ENTA-Rhinoplasty
Body dysmorphic disorder is a serious psychiatric condition that we all need to be aware of when contemplating aesthetic surgery. It can present in children as well as adults. Prof Vieira and Dr de Carvalho discuss the tell-tale signs and...

Winners announced for 2024 Hearing Technology Innovator Awards

6 September 2024
Hearing Health & Technology Matters (HHTM), an online resource for hearing professionals and consumers with hearing loss, has today revealed the winners of its fifth annual Hearing Technology Innovator Awards™. Through this esteemed awards programme, HHTM continues to honour innovation...

2014: Are today’s implantable devices better than conventional solutions for patients with conductive or mixed hearing loss?

6 June 2017 | | ENTA-Audiology - Adult, ENTA-Audiology - Paediatric, ENTA-Auditory Implants, ENTA-ENT, ENTA-Otology, ENTA-Paediatrics
Patients with conductive or mixed hearing loss become candidates for amplification when reconstructive surgery is not viable. Three common amplification options are conventional acoustic devices, such as behind-the-ear devices (BTEs), (implantable) bone-conduction devices and active middle ear implants. The goal...

In conversation with David Stockdale

27 April 2022 | | ENTA-Audiology - Adult, ENTA-Audiology - Diagnostic, ENTA-Otology
David Stockdale is stepping away from the British Tinnitus Association (BTA) after 12 years, during which time the organisation has become transformed. Prof David Baguley met with David in the spring sunshine to reflect on past, present and future of...

WCA Innovation Prize

8 November 2024
At the World Congress of Audiology in Paris in September, a special prize was announced for the best innovation that addresses an unmet medical need. Candidates were selected from domains such as clinical trials or medical devices, and given five minutes and five slides to pitch in front of an international jury of researchers, clinicians, economists and industry professionals.

Systemic agents in thyroid cancer

1 July 2017 | | ENTA-ENT, ENTA-Head & Neck, ENTA-Thyroid / Parathyroid Surgery
For those patients who have disseminated or unresectable thyroid cancer, Dr Arabella Hunt and Dr Kate Newbold review systemic treatments, their differences, toxicities and outcomes. Thyroid cancer is the most common endocrine malignancy. It is subdivided into differentiated (papillary, follicular...

Pre-clinical development of magnetic delivery of therapy to middle and inner ears

1 March 2014 | | ENTA-ENT, ENTA-Otology
Why are we developing this technology? A key problem in drug delivery is getting the therapy to the right place in the body, which is especially challenging for targets that are small, deep and are protected or surrounded by anatomical...

Adjoin™ bone conduction system

1 May 2016 | | ENTA-Auditory Implants, ENTA-Otology
Patrik Westerkull (PW), Otorix AB, and Ann-Louise McDermott (A-LM), ENT Consultant at Birmingham Children’s Hospital, tell us about the Adjoin bone conduction device, a non-surgical bone-conduction option developed by Otorix. They explain how the product works, the background to the...

Thyroid nodules – time for a rational imaging approach

1 May 2014 | | ENTA-ENT, ENTA-Thyroid / Parathyroid Surgery
“The more you know, the harder it is to take decisive action. Once you become informed, you start seeing complexities and shades of gray. You realize that nothing is as clear as it first appears. Ultimately, knowledge is paralyzing.” Calvin,...